ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL | N050529 | ROSS LABORATORIES DIV ABBOTT LABORATORIES INC
1 strength0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 200MG BASE/5ML;EQ 600MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
0 patents0 exclusivities▴
GRANULE;ORAL | Approved: Approved Prior to Jan 1, 1982
No patent or exclusivity listings for this strength.